SHANGHAI, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The 20th JCtrans Global Freight Forwarders Conference, hosted by JCtrans, successfully concluded at the Shanghai World Expo Center after three days of vibrant exchanges and collaboration. Under the theme “Building Your Reliable Supply Chain Service”, the event attracted 1,980 logistics leaders and professionals from 95 countries and regions, marking another milestone in the evolution of the global logistics community. Through a diverse program including the Openin ...

When fibers themselves possess sensing and thinking capabilities, technology can understand and improve human sleep in a more natural wayDONGGUAN, China, Nov. 06, 2025 (GLOBE NEWSWIRE) -- On October 27, 2025, an MIT (Massachusetts Institute of Technology) lab held a closed-door demonstration event, releasing its latest research achievement: the "FiberCircuits" intelligent fiber platform. This platform was led by MIT tenured professor and academic head of the MIT lab, Director of the Sensor and Ambient Intel ...

Company announcement no. 30/2025 Strengthening efficiency – focusing on renewed growth The third quarter of 2025 reflected continued market caution, particularly in the Nordics, where customer decision-making remained cautious. Revenue declined by 7% in Q3 2025, and adjusted EBITDA amounted to DKK 24m, corresponding to a margin of 6.9%. We maintain the full-year outlook last updated in July 2025, supported by signs of improving customer activity and a solid pipeline. “We are navigating a challenging market ...

核心技术进展 - 公司宣布将在2025年ESMO AI & Digital Oncology会议上展示其专有的VacDesignR®计算工具 [1] - VacDesignR®是一种计算设计引擎，可优化MVA载体的重组质粒架构，这是myvac®平台的核心组件 [3] - 该工具通过最大限度地减少不必要的同源重组并智能选择用于盒式组装的肽序列，显著提高了生产可靠性和载体质量 [3] - VacDesignR®是受专利和基于WO2021/130210的专利申请保护的计算机辅助方法 [6] 平台整合与临床关联 - VacDesignR®简化了基于重组MVA载体的设计和生产，从而能够更快、更可靠地制造个体化新抗原治疗疫苗 [2] - 通过myvac®平台开发的个体化免疫疗法基于MVA病毒载体，其设计已利用VacDesignR®工具，该疗法目前正在I/II期临床试验中进行评估 [2] - TG4050是公司基于myvac®平台的主要候选产品，旨在用于头颈癌患者手术和辅助治疗后的治疗 [4][8] 未来发展策略 - VacDesignR®的未来迭代将纳入基于人工智能的组件，以进一步提高性能和可扩展性 [4] - 此举支持公司加速个体化治疗疫苗生产时间表的战略 [4] - 公司在ESMO AI & Digital Oncology会议上的参与凸显了其将病毒载体个体化癌症疫苗与疫苗设计工具相结合的先锋角色 [5] 公司背景与平台信息 - 公司是一家专注于设计和开发用于治疗癌症的靶向免疫疗法的生物技术公司 [8] - 公司的临床阶段项目包括一系列基于病毒载体的免疫治疗药物 [8] - myvac®是一个基于病毒载体的个体化免疫治疗平台，旨在刺激患者的免疫系统，利用其自身癌症特异性突变来识别和摧毁肿瘤 [10] - 公司还拥有专有平台Invir.IO®，用于设计新一代多功能溶瘤病毒 [10]

Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, has launched its new generation of intelligent mailing systems in the UK, designed to simplify and modernise how organisations handle physical mail. As businesses manage increasingly complex postal rates and a growing mix of communication channels, the new Quadient iX-Series, featuring the iX-4 for office use, iX-6 for medium mail volumes and the high-performance iX-8 for large mailrooms, deliv ...

The two Groups have reached a binding agreement on the main principles of their collaboration, with a view to deploying a capacity of one million tonnes in the long term,Starting with the construction of a plant in China with a processing capacity of 50,000 tonnes of PET waste per year.This collaboration remains subject to the signing of final agreements. Clermont-Ferrand (France), November 6, 2025 (08:30am CET). Following the Letter of intent signed on June 24, 2024, CARBIOS (Euronext Growth Paris: ALCRB) ...

公司业务与市场地位 - 公司是领先的欧洲资本市场基础设施，业务覆盖从上市、交易、清算、结算到托管的全价值链 [2] - 公司运营欧洲领先的电子固定收益交易市场MTS和欧洲电力市场Nord Pool，并通过其子公司提供清算和结算服务 [2] - 截至2025年9月，公司在比利时、法国、爱尔兰、意大利、荷兰、挪威和葡萄牙的受监管交易所拥有超过1,700家上市公司，总市值达6.5万亿欧元 [3] - 公司拥有强大的蓝筹股业务和全球最大的债务及基金上市中心，处理欧洲25%的亮灯股权交易 [3] - 公司产品范围包括股票、外汇、ETF、债券、衍生品、大宗商品和指数 [3] 运营信息与投资者沟通 - 公司于2025年11月6日宣布了2025年10月的交易量数据 [1] - 月度及历史交易量表格可在公司官网的投资者关系栏目下获取 [1] - 公司为分析师、投资者和媒体提供了不同地区的具体联系人信息 [1] - 公司鼓励通过其媒体中心、X平台和LinkedIn获取最新消息和资源 [4]

23, Place des Carmes-Déchaux - 63000 CLERMONT-FERRAND Information about securities repurchasing programRegulated informationIssuer social denomination: Michelin – LEI 549300SOSI58J6VIW052 Types of securities: ordinary shares – Code ISIN FR001400AJ45Date : November 6th, 2025 Issuer NameIssuer codeTransactiondateISIN CodeDaily total volume (in number of actions)Daily weighted average price of shares acquiredPlatformCompagnie Générale des Etablissements Michelin549300SOSI58J6VIW052<td style="width:79.2px;;text ...

INVL Asset Management, a subsidiary of the leading asset management group in the Baltics, Invalda INVL, has launched a new investment fund, INVL Defence Infrastructure Fund I, which will participate in the tender for the construction of the Rūdninkai military town. The fund will act as a financial partner in the project. The Bank of Lithuania has approved the fund’s rules. “Taking into account the geopolitical situation in the region, we see that the defence sector is one of the most relevant areas where we ...

Harvia Plc, Interim report 6 November 2025 at 9:00 a.m. EET Harvia Q3 2025: Strong revenue growth – all regions contributing This release is a summary of Harvia Plc’s Interim Report January–September 2025. The complete report is attached to this release as a pdf file. It is also available on Harvia’s website at https://harviagroup.com/. Highlights of the review period July–September 2025: Revenue increased by 18.8% to EUR 46.0 million (38.7). At comparable exchange rates, revenue increased by 22.3% to EUR 4 ...